Hamlet BioPharma invites you to the investors’ meeting to be held on the 22nd of May 2026, at 12:00.

Please click on the link below to participate in the meeting

https://youtube.com/live/3TgHDRRadfk?feature=share

For further information, please contact

Catharina Svanborg, Chairman of the Board, Hamlet BioPharma AB, +46 709 42 65 49,

catharina.svanborg@hamletpharma.com

Jakob Testad, CEO, Hamlet BioPharma AB, +46 708 48 42 10,

jakob.testad@hamletbiopharma.com